WELL - TSI update - Jan 17 WELL HEALTH TECHNOLOGIES CORP., $6.53, is a buy. The company (symbol WELL on Toronto) owns and operates Canada’s largest network of clinics supporting primary care, specialized care and diagnostics services. As of September 30, 2024, the company had a total of 110 physical facilities across Canada.
In the U.S., WELL Health provides healthcare services and solutions targeting specialized markets such as gastrointestinal, women’s health, primary care, and mental disorders.
In 2024, WELL completed seven acquisitions. They include one of the largest physician recruitment firms in Canada, two Canadian Primary Care Clinics, and one provider staffing firm in the U.S.
These new assets will add $100 million to the company’s annual revenue of about $958 million. WELL is also looking at more acquisitions that would add another $65 million in annual revenues.
These new businesses will probably lift WELL’s projected earnings, from $0.24 a share in 2024 to $0.32 in 2025. The stock, which has soared 60% in the past year, trades at a reasonable 20.4 times that 2025 forecast.
Growth by acquisition adds risk, but WELL Health aims to cut that risk by buying complementary businesses. As well, the Canadian health-care sector is a government-backed, recession-resilient industry. WELL Health is a buy for aggressive investors.